Merck Wins 1st State Fosamax Trial In NJ

Law360, New York (February 14, 2011, 4:19 PM EST) -- A New Jersey jury sided with Merck & Co. Inc. on Monday in the first Fosamax case to go to trial in a state court, freeing the company from claims its osteoporosis drug was to blame for a woman's jaw bone decay.

The jury in the Superior Court for Atlantic County, New Jersey, found in favor of Merck, rejecting claims by the plaintiff — who took Fosamax from 1999 to 2006 — that she suffered jaw problems linked to her use of the drug after having...
To view the full article, register now.